Mycolio DISINFECTANT & Mycolio DISINFECTANT WIPES have a unique formulation of four active ingredients that work synergistically to create an unparalleled broad spectrum disinfectant ideal for daily use in dental offices. In addition to disinfecting against HIV-1, mycolio DISINFECTANT & mycolio DISINFECTANT WIPES are also effective against Hepatitis B (DHBV) and Hepatitis C (BVDV) to significantly reduce the of risk of cross-infection from these three commonly feared bloodborne viral pathogens. mycolio DISINFECTANT & mycolio DISINFECTANT WIPES may be used on a multitude of non porous hard surfaces and is also gentle enough to use on dental chairs!*
Wipes/Refill Pouches - EPA Reg. No. 88897-1-90841
Spray/Refill Jug - EPA Reg. No. 88897-2-90841
If referencing the EPA’s List N: Disinfectants for Use Against SARS-CoV-2 please note that mycolio is listed under the product name Panther.
Information Regarding the Novel Coronavirus 2019-nCoV
mycolio DISINFECTANT qualifies for emerging viral pathogen claims per the EPA’s ‘Guidance to Registrants: Process for Making Claims Against Emerging Viral Pathogens not on EPA-Registered Disinfectant Labels’ when used in accordance with the appropriate use directions indicated below.
This product meets the criteria to make claims against certain emerging viral pathogens from the following viral category:
|For an emerging viral pathogen that is an…||…following the directions for use for the following organisms on the label:|
|Enveloped virus||Adenovirus type 5 [ATCC VR-5]|
mycolio DISINFECTANT has demonstrated effectiveness against viruses similar to Novel Coronavirus 2019-nCoV on hard, non-porous surfaces. Therefore, mycolio DISINFECTANT can be used against Novel Coronavirus 2019-nCoV when used in accordance with the directions for use against Adenovirus type 5 [ATCC VR-5] on hard, non-porous surfaces. Refer to the CDC website at https://www.cdc.gov/coronavirus/2019-nCoV/summary.html for additional information.